PRFX
Painreform LtdNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.31M
P/E Ratio
—
EPS
$-7.47
Beta
0.71
52W High
$12.25
52W Low
$1.80
50-Day MA
$2.73
200-Day MA
$5.21
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Painreform Ltd
PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period of post-surgical pain relief in Israel. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | 17,000 |
| Gross Profit (TTM) | -53,000 |
| EBITDA | $-4.35M |
| Operating Margin | -16200.00% |
| Return on Equity | -90.40% |
| Return on Assets | -38.80% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $10.29 |
| Price-to-Book | 0.26 |
| Price-to-Sales (TTM) | 136.12 |
| EV/Revenue | - |
| EV/EBITDA | -2.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 844,550 |
| Float | 808,620 |
| % Insiders | 4.48% |
| % Institutions | 2.56% |
Historical Volatility
HV 10-Day
139.04%
HV 20-Day
120.29%
HV 30-Day
102.19%
HV 60-Day
122.91%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/14/2026